Pharmaceuticals Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Pharmaceuticals Industry Research & Market Reports
-
Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the ... Read More
-
France Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Japan Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Italy Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
Serbia Pharmaceuticals and Healthcare Report Q3 2017
...and healthcare expenditure. Headline Expenditure ProjectionsPharmaceuticals: RSD92.1bn (USD822mn) in 2016 to RSD94.2bn (USD803mn) in 2017; +2.3% in localcurrency terms and -2.3% in US dollar terms. Forecast unchanged from previous quarter.Healthcare: RSD423.4bn (USD3.78bn) in 2016 to ... Read More
-
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2017
...support rising demand for chronic diseasetreatment and higher-value medicines. That said, the relatively small drug market by regional standards,together with an unattractive policy environment and drug pricing controls, will continue to make of SriLanka a ... Read More
-
Colombia Pharmaceuticals and Healthcare Report Q3 2017
...high burden of both communicable and non-communicabledisease. Headline Expenditure Projections Pharmaceuticals: COP9,581bn (USD3.14bn) in 2016 to COP10,092bn (USD3.54bn) in 2017; +5.3% inlocal currency and +12.9% in US dollars. Forecast broadly unchanged from previous quarter. Healthcare: ... Read More
-
Ukraine Pharmaceuticals and Healthcare Report Q3 2017
...and affordability of treatments;however the unstable political environment poses significant downside risk to this scenario. Headline Expenditure Projections Pharmaceuticals: UAH54.0bn (USD2.10bn) in 2016 to UAH64.9bn (USD2.38bn) in 2017; +20.2% inlocal currency terms and +13.1% in ... Read More
-
Croatia Pharmaceuticals and Healthcare Report Q3 2017
...unemployed. Given the country's need to reduce its fiscaldeficit, we foresee a shift towards increasing private healthcare contributions. Headline Expenditure Projections Pharmaceuticals: HRK6.85bn (USD1.01bn) in 2016 to HRK6.98bn (USD937mn) in 2017; 2.0% inlocal currency and ... Read More
-
Germany Pharmaceuticals and Healthcare Report Q3 2017
...of cost-containmentmeasures, including manufacturer rebates, which will put a lid on their local revenues. Headline Expenditure Projections Pharmaceuticals: EUR58.33bn (USD60.80bn) in 2016 to EUR55.55bn (USD58.33bn) in 2017; +1.1%in local currency terms and -4.1% in US ... Read More
-
Spain Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
UK Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV ... Read More
-
Slovakia Pharmaceuticals and Healthcare Report Q3 2017
...years. The country's parliament has adopted anexpansionary budget on the back of increasing revenues, which is owed to higher employment andincreases in wage. Headline Expenditure Projections Pharmaceuticals: EUR1.98bn (USD2.19bn) in 2016 to EUR2.06bn (USD2.16bn) in ... Read More
-
Germany Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT ... Read More
-
US Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review
...presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV ... Read More
-
Kuwait Pharmaceuticals and Healthcare Report Q3 2017
...as a parliament which has consistently blockedthe government's reform efforts. While these healthcare reforms are still likely to be implemented, changesto the election law reform mean they are vulnerable to lengthy delays as political tensions ... Read More
-
Global Rehabilitation Robots Market 2017-2021
...robots are employed for various human body activities supported by hands, legs, ankle, wrist, fingers and others. These robots are used by patients suffering from major body disorders like paralytic body parts. Technavio’s analysts forecast ... Read More
-
Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H1 2017
...or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) pipeline Target constitutes close to 11 molecules. Out of which approximately 11 molecules are developed by Companies. The latest report Tryptophan 2,3 Dioxygenase - Pipeline ... Read More
-
Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H1 2017
...Mch 2 or CASP6 or EC 3.4.22.59) pipeline Target constitutes close to 5 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. Caspase 6 (Apoptotic Protease Mch 2 ... Read More
-
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review, H1 2017
...Factor Erythroid Derived 2 Like 2 or NFE2L2) - Nuclear factor (erythroid-derived 2)-like 2 or Nrf2 is a transcription factor encoded by the NFE2L2 gene. It binds to antioxidant response elements in the promoter regions ... Read More
-
Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or HLA B Associated Transcript 8 or Histone H3 K9 Methyltransferase 3 or Lysine N Methyltransferase 1C or Protein G9a or EHMT2 or EC 2.1.1.43) - Pipeline Review, H1
...EC 2.1.1.43) - Pipeline Review, H1 2017 Summary According to the recently published report 'Histone Lysine N Methyltransferase EHMT2 - Pipeline Review, H1 2017'; Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 ... Read More
-
Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H1 2017
...H1 2017 Summary According to the recently published report 'Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H1 2017'; Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low ... Read More
-
Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H1 2017
...Integrin Associated Protein or Protein MER6 or CD47) pipeline Target constitutes close to 13 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Leukocyte Surface ... Read More
-
Competing in the Global Sexually-Transmitted Disease (STD)Testing Market, 2017-2021
...forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on ... Read More
-
E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H1 2017
...published report 'E3 Ubiquitin Protein Ligase Mdm2 - Pipeline Review, H1 2017'; E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC ... Read More
